In addition to C14-Tri-LAN-Gly, we have also studied the effect of another NOD1 agonist C12-iE-DAP, which is widely used, on LPS/D-GalN-induced hepatitis. This evidence concerns the gene NOD1 and hepatitis A virus infection.